Dementia is most commonly caused by Alzheimer's disease (AD) pathology (plaques and tangles);however AD pathology is very commonly mixed with other pathologies which further lower cognition and increase the odds of dementia in older persons.TDP-43 pathology, a marker of an uncommon presenile dementia syndrome called Frontotemporal Lobar Degeneration (FTLD-TDP), has recently been identified in a large proportion of older brains especially those with AD pathology. The role of TDP-43 pathology in aging and AD is unknown but there is increasing evidence that it is detrimental. It is not known whether TDP-43 pathology represents a third pathology of AD or a separate coexisting disease. Our overarching hypothesis is that age-related TDP-43 pathology represents a separate pathologic process associated with a dementia syndrome with a distinct cognitive phenotype and specific genetic risk factors that are separate from AD. We propose to address these hypotheses by performing a epidemiologic study of TDP-43 pathology in aging and AD, by leveraging existing clinical, pathologic, and genetic data from 2 epidemiologic clinical-pathologic cohort studies, and collecting new TDP-43 pathology data on 1400 brains. First, using a series of analytic models, we propose to test whether TDP-43 pathology is a separate aging pathology or mediates the effects of AD pathology. Second, we propose to investigate whether TDP-43 pathology in aging is associated with a specific cognitive profile and separately increases the rate of cognitive decline. We also propose to examine the role of TDP-43 pathology in older persons without dementia, and separately examine TDP-43 in older persons without AD pathology. If TDP-43 pathology represents coexisting FTLD-TDP, the clinical profile may show early and prominent executive and language impairment rather than an AD phenotype in each of these groups. Third because the oldest-old are the fastest growing segment of the population and because AD pathology is not as relevant in this age-group, we propose to investigate the role of TDP-43 pathology in this important subgroup of older persons. Finally in the last two aims we propose to investigate the association of genetic polymorphisms (SNPs) with TDP-43 pathology and cognition. We propose that SNPs associated with FTLD are related to TDP-43 pathology in aging;whereas SNPs associated with clinical AD are related to AD pathology in aging. We present compelling preliminary data in the support of these aims. Results from these proposed studies will fill an important gap in scientific knowledge and are likely to impact future studies of prevention and treatment of cognitive impairment and dementia in aging.

Public Health Relevance

The number of older persons in society is rapidly expanding and creating a looming epidemic of cognitive impairment and dementia. There is compelling data that TDP-43 pathology, a recently recognized age-related pathology which often coexists with AD pathology, is strongly and separately related to cognitive impairment and dementia in the old and oldest-old. Data derived from the proposed clinical, pathologic and genetic studies of TDP-43 pathology in aging will fill an important gap in scientific knowledge and are likely to significantly alter the course of future research in the prevention and treatment of cognitive impairment and dementia in aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG042210-02
Application #
8484330
Study Section
Special Emphasis Panel (ZRG1-PSE-K (03))
Program Officer
Anderson, Dallas
Project Start
2012-07-01
Project End
2017-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
2
Fiscal Year
2013
Total Cost
$395,684
Indirect Cost
$123,585
Name
Rush University Medical Center
Department
Neurosciences
Type
Schools of Medicine
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kapasi, Alifiya; DeCarli, Charles; Schneider, Julie A (2017) Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 134:171-186
Ramos-Miguel, Alfredo; Sawada, Ken; Jones, Andrea A et al. (2017) Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol 133:395-407
Ramos-Miguel, Alfredo; García-Sevilla, Jesús A; Barr, Alasdair M et al. (2017) Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample. Mol Neurodegener 12:26
Boyle, Patricia A; Yu, Lei; Wilson, Robert S et al. (2017) Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol :
Yu, Lei; Lutz, Michael W; Farfel, Jose M et al. (2017) Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Alzheimers Dement 13:1380-1388
Pool, Lindsay R; Weuve, Jennifer; Wilson, Robert S et al. (2016) Occupational cognitive requirements and late-life cognitive aging. Neurology 86:1386-92
Arvanitakis, Zoe; Capuano, Ana W; Leurgans, Sue E et al. (2016) Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol 15:934-943
James, Bryan D; Wilson, Robert S; Boyle, Patricia A et al. (2016) TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain 139:2983-2993
Crane, Paul K; Gibbons, Laura E; Dams-O'Connor, Kristen et al. (2016) Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol 73:1062-9
Farfel, Jose M; Yu, Lei; De Jager, Philip L et al. (2016) Association of APOE with tau-tangle pathology with and without ?-amyloid. Neurobiol Aging 37:19-25

Showing the most recent 10 out of 34 publications